Korean Drug Co., Ltd. (KOSDAQ:014570)
3,360.00
+50.00 (1.51%)
At close: Jul 31, 2026
Korean Drug Market Cap
Korean Drug has a market cap or net worth of 36.66 billion as of July 31, 2026. Its market cap has decreased by -28.21% in one year.
Market Cap
36.66B
Enterprise Value
2.21B
Revenue
62.76B
Ranking
n/a
PE Ratio
5.28
Stock Price
3,360.00
ChartMarket Cap Chart
Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 36.66B, an increase of 192.38%. That is a compound annual growth rate of 5.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 36.66B | -21.86% |
| Dec 30, 2025 | 46.92B | -6.42% |
| Dec 30, 2024 | 50.14B | -36.00% |
| Dec 28, 2023 | 78.35B | -8.30% |
| Dec 29, 2022 | 85.44B | -12.32% |
| Dec 30, 2021 | 97.44B | -13.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RP Bio | 51.56B |
| Jin Yang Pharmaceutical | 49.32B |
| Organoidsciences | 48.93B |
| Samik Pharmaceutical Company LTD. | 44.90B |
| GeneBioTech Co. ,Ltd | 42.62B |
| Eagle Veterinary Technology Co.,Ltd | 38.05B |
| Korea Arlico Pharm | 36.25B |
| Kyung Nam Pharm | 29.43B |